17alpha-ethynylestradiol increases expression ISO RGD:1319669 6480464 Ethinyl Estradiol results in increased expression of COL8A1 mRNA CTD PMID:17942748 17beta-estradiol increases expression ISO RGD:1319669 6480464 Estradiol results in increased expression of COL8A1 mRNA CTD PMID:19484750 17beta-estradiol multiple interactions ISO RGD:1319668 6480464 [Estradiol co-treated with TGFB1 protein] results in increased expression of COL8A1 mRNA CTD PMID:30165855 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1319669 6480464 AHR protein inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of COL8A1 mRNA] CTD PMID:14728982 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1319668 6480464 Tetrachlorodibenzodioxin affects the expression of COL8A1 mRNA CTD PMID:36370075 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of COL8A1 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of COL8A1 mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1319669 6480464 Tetrachlorodibenzodioxin results in decreased expression of COL8A1 mRNA CTD PMID:15034205 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1319669 6480464 Tetrachlorodibenzodioxin results in increased expression of COL8A1 mRNA CTD PMID:14728982 2-amino-2-deoxy-D-glucopyranose multiple interactions EXP 6480464 Glucosamine inhibits the reaction [IL1B results in increased expression of COL8A1 mRNA], IL1B inhibits the reaction [Glucosamine results in decreased expression of COL8A1 mRNA] CTD PMID:17109745 2-amino-2-deoxy-D-glucopyranose decreases expression EXP 6480464 Glucosamine results in decreased expression of COL8A1 mRNA CTD PMID:17109745 3,4-dichloroaniline decreases expression ISO RGD:1319668 6480464 3, 4-dichloroaniline results in decreased expression of COL8A1 mRNA CTD PMID:24172598 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1319668 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of COL8A1 mRNA CTD PMID:28628672 3-methylcholanthrene decreases expression ISO RGD:1319669 6480464 Methylcholanthrene results in decreased expression of COL8A1 mRNA CTD PMID:20713471 4,4'-sulfonyldiphenol multiple interactions ISO RGD:1319669 6480464 [bis(4-hydroxyphenyl)sulfone co-treated with Tretinoin] results in decreased expression of COL8A1 mRNA CTD PMID:30951980 4,4'-sulfonyldiphenol increases expression ISO RGD:1319668 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of COL8A1 protein CTD PMID:34186270 4,4'-sulfonyldiphenol increases expression ISO RGD:1319669 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of COL8A1 mRNA CTD PMID:30951980 4-hydroxyphenyl retinamide decreases expression ISO RGD:1319669 6480464 Fenretinide results in decreased expression of COL8A1 mRNA CTD PMID:28973697 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of COL8A1 mRNA CTD PMID:24780913 6-propyl-2-thiouracil decreases expression ISO RGD:1319669 6480464 Propylthiouracil results in decreased expression of COL8A1 mRNA CTD PMID:36706583 acrylamide decreases expression ISO RGD:1319669 6480464 Acrylamide results in decreased expression of COL8A1 mRNA CTD PMID:35032568 aflatoxin B1 decreases methylation ISO RGD:1319668 6480464 Aflatoxin B1 results in decreased methylation of COL8A1 exon, Aflatoxin B1 results in decreased methylation of COL8A1 gene CTD PMID:27153756 , PMID:30157460 aflatoxin B1 increases methylation ISO RGD:1319668 6480464 Aflatoxin B1 results in increased methylation of COL8A1 intron CTD PMID:30157460 Aflatoxin B2 alpha decreases methylation ISO RGD:1319668 6480464 aflatoxin B2 results in decreased methylation of COL8A1 exon CTD PMID:30157460 aldehydo-D-glucosamine multiple interactions EXP 6480464 Glucosamine inhibits the reaction [IL1B results in increased expression of COL8A1 mRNA], IL1B inhibits the reaction [Glucosamine results in decreased expression of COL8A1 mRNA] CTD PMID:17109745 aldehydo-D-glucosamine decreases expression EXP 6480464 Glucosamine results in decreased expression of COL8A1 mRNA CTD PMID:17109745 all-trans-retinoic acid multiple interactions ISO RGD:1319669 6480464 [bis(4-hydroxyphenyl)sulfone co-treated with Tretinoin] results in decreased expression of COL8A1 mRNA more ... CTD PMID:30951980 aristolochic acid A decreases expression ISO RGD:1319668 6480464 aristolochic acid I results in decreased expression of COL8A1 mRNA CTD PMID:33212167 arsane multiple interactions ISO RGD:1319668 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of COL8A1 mRNA CTD PMID:32525701 arsenic atom multiple interactions ISO RGD:1319668 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of COL8A1 mRNA CTD PMID:32525701 arsenite(3-) decreases expression ISO RGD:1319669 6480464 arsenite results in decreased expression of COL8A1 mRNA CTD PMID:15894712 arsenite(3-) multiple interactions ISO RGD:1319669 6480464 [arsenite co-treated with Benzo(a)pyrene] results in decreased expression of COL8A1 mRNA CTD PMID:15894712 atrazine decreases expression EXP 6480464 Atrazine results in decreased expression of COL8A1 mRNA CTD PMID:36841081 benzo[a]pyrene multiple interactions ISO RGD:1319669 6480464 [arsenite co-treated with Benzo(a)pyrene] results in decreased expression of COL8A1 mRNA, AHR protein promotes the reaction [Benzo(a)pyrene results in decreased expression of COL8A1 mRNA] CTD PMID:15034205 , PMID:15894712 benzo[a]pyrene increases expression ISO RGD:1319668 6480464 Benzo(a)pyrene results in increased expression of COL8A1 mRNA CTD PMID:32234424 benzo[a]pyrene affects methylation ISO RGD:1319668 6480464 Benzo(a)pyrene affects the methylation of COL8A1 5' UTR CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:1319669 6480464 Benzo(a)pyrene results in increased expression of COL8A1 mRNA CTD PMID:27195522 benzo[a]pyrene decreases expression ISO RGD:1319669 6480464 Benzo(a)pyrene results in decreased expression of COL8A1 mRNA CTD PMID:15034205 , PMID:15894712 beta-D-glucosamine multiple interactions EXP 6480464 Glucosamine inhibits the reaction [IL1B results in increased expression of COL8A1 mRNA], IL1B inhibits the reaction [Glucosamine results in decreased expression of COL8A1 mRNA] CTD PMID:17109745 beta-D-glucosamine decreases expression EXP 6480464 Glucosamine results in decreased expression of COL8A1 mRNA CTD PMID:17109745 bis(2-chloroethyl) sulfide decreases expression ISO RGD:1319668 6480464 Mustard Gas results in decreased expression of COL8A1 mRNA CTD PMID:25102026 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of COL8A1 mRNA CTD PMID:25181051 bisphenol A increases expression ISO RGD:1319668 6480464 bisphenol A results in increased expression of COL8A1 protein CTD PMID:34186270 bisphenol A increases expression ISO RGD:1319669 6480464 bisphenol A results in increased expression of COL8A1 mRNA CTD PMID:30245210 more ... bisphenol A multiple interactions ISO RGD:1319669 6480464 [bisphenol A co-treated with Tretinoin] results in decreased expression of COL8A1 mRNA CTD PMID:30951980 bisphenol A decreases expression ISO RGD:1319668 6480464 bisphenol A results in decreased expression of COL8A1 mRNA CTD PMID:27685785 bisphenol F multiple interactions ISO RGD:1319669 6480464 [bisphenol F co-treated with Tretinoin] results in decreased expression of COL8A1 mRNA CTD PMID:30951980 bisphenol F multiple interactions ISO RGD:1319668 6480464 [bisphenol F co-treated with Fulvestrant] results in decreased methylation of COL8A1 gene CTD PMID:31601247 bisphenol F decreases expression ISO RGD:1319669 6480464 bisphenol F results in decreased expression of COL8A1 mRNA CTD PMID:36706583 bisphenol F increases expression ISO RGD:1319669 6480464 bisphenol F results in increased expression of COL8A1 mRNA CTD PMID:30951980 Butylparaben increases expression ISO RGD:1319668 6480464 butylparaben results in increased expression of COL8A1 mRNA CTD PMID:17121429 C60 fullerene decreases expression EXP 6480464 fullerene C60 results in decreased expression of COL8A1 mRNA CTD PMID:19167457 cadmium dichloride increases expression ISO RGD:1319668 6480464 Cadmium Chloride results in increased expression of COL8A1 mRNA CTD PMID:12160620 cadmium dichloride multiple interactions ISO RGD:1319669 6480464 [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of COL8A1 mRNA CTD PMID:19840844 cadmium dichloride decreases expression ISO RGD:1319668 6480464 Cadmium Chloride results in decreased expression of COL8A1 mRNA CTD PMID:18560533 calcitriol decreases expression ISO RGD:1319668 6480464 Calcitriol results in decreased expression of COL8A1 mRNA CTD PMID:26485663 calcium dichloride increases expression ISO RGD:1319668 6480464 Calcium Chloride results in increased expression of COL8A1 protein CTD PMID:25824407 CGP 52608 multiple interactions ISO RGD:1319668 6480464 CGP 52608 promotes the reaction [RORA protein binds to COL8A1 gene] CTD PMID:28238834 choline multiple interactions ISO RGD:1319669 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of COL8A1 mRNA CTD PMID:20938992 cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of COL8A1 mRNA CTD PMID:24386269 copper(II) sulfate decreases expression ISO RGD:1319668 6480464 Copper Sulfate results in decreased expression of COL8A1 mRNA CTD PMID:20599845 copper(II) sulfate increases expression ISO RGD:1319668 6480464 Copper Sulfate results in increased expression of COL8A1 mRNA CTD PMID:20599845 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of COL8A1 mRNA CTD PMID:26577399 dexamethasone decreases expression ISO RGD:1319669 6480464 Dexamethasone results in decreased expression of COL8A1 mRNA CTD PMID:22733784 dexamethasone multiple interactions ISO RGD:1319668 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of COL8A1 mRNA CTD PMID:28628672 dextran sulfate multiple interactions ISO RGD:1319669 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of COL8A1 mRNA CTD PMID:29950665 diallyl trisulfide decreases expression ISO RGD:1319668 6480464 diallyl trisulfide results in decreased expression of COL8A1 mRNA CTD PMID:34995734 diazinon decreases expression EXP 6480464 Diazinon results in decreased expression of COL8A1 mRNA CTD PMID:29108742 Didecyldimethylammonium decreases expression ISO RGD:1319668 6480464 didecyldimethylammonium results in decreased expression of COL8A1 mRNA CTD PMID:32763356 dioxygen increases expression ISO RGD:1319669 6480464 Oxygen deficiency results in increased expression of COL8A1 mRNA CTD PMID:24205000 dorsomorphin multiple interactions ISO RGD:1319668 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin increases expression ISO RGD:1319669 6480464 Doxorubicin results in increased expression of COL8A1 mRNA CTD PMID:15033991 doxorubicin decreases expression ISO RGD:1319668 6480464 Doxorubicin results in decreased expression of COL8A1 mRNA CTD PMID:29803840 ethanol multiple interactions ISO RGD:1319668 6480464 [[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of COL8A1 mRNA CTD PMID:29432896 fenamidone increases expression ISO RGD:1319669 6480464 fenamidone results in increased expression of COL8A1 mRNA CTD PMID:27029645 folic acid multiple interactions ISO RGD:1319669 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of COL8A1 mRNA CTD PMID:20938992 fulvestrant multiple interactions ISO RGD:1319668 6480464 [bisphenol F co-treated with Fulvestrant] results in decreased methylation of COL8A1 gene CTD PMID:31601247 furan increases expression EXP 6480464 furan results in increased expression of COL8A1 mRNA CTD PMID:27387713 geldanamycin increases expression ISO RGD:1319668 6480464 geldanamycin results in increased expression of COL8A1 mRNA CTD PMID:26705709 genistein increases expression ISO RGD:1319669 6480464 Genistein results in increased expression of COL8A1 mRNA CTD PMID:32186404 glycidol increases expression EXP 6480464 glycidol results in increased expression of COL8A1 mRNA CTD PMID:24395379 indometacin multiple interactions ISO RGD:1319668 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of COL8A1 mRNA CTD PMID:28628672 L-methionine multiple interactions ISO RGD:1319669 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of COL8A1 mRNA CTD PMID:20938992 lead diacetate decreases expression EXP 6480464 lead acetate results in decreased expression of COL8A1 mRNA CTD PMID:11578147 , PMID:22641619 lipopolysaccharide multiple interactions ISO RGD:1319668 6480464 [S-(1, 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of COL8A1 mRNA CTD PMID:35811015 lipopolysaccharide increases expression ISO RGD:1319668 6480464 Lipopolysaccharides results in increased expression of COL8A1 mRNA CTD PMID:35811015 manganese(II) chloride increases expression EXP 6480464 manganese chloride results in increased expression of COL8A1 mRNA CTD PMID:28801915 mercury dibromide multiple interactions ISO RGD:1319668 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL8A1 mRNA CTD PMID:27188386 methotrexate affects expression ISO RGD:1319669 6480464 Methotrexate affects the expression of COL8A1 mRNA CTD PMID:18502557 methoxychlor affects methylation EXP 6480464 Methoxychlor affects the methylation of COL8A1 gene CTD PMID:35440735 methylparaben increases expression ISO RGD:1319668 6480464 methylparaben results in increased expression of COL8A1 mRNA CTD PMID:17121429 N-methyl-N'-nitro-N-nitrosoguanidine multiple interactions ISO RGD:1319669 6480464 [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of COL8A1 mRNA more ... CTD PMID:19840844 nickel atom decreases expression ISO RGD:1319668 6480464 Nickel results in decreased expression of COL8A1 mRNA CTD PMID:24768652 , PMID:25583101 nickel sulfate decreases expression ISO RGD:1319668 6480464 nickel sulfate results in decreased expression of COL8A1 mRNA CTD PMID:22714537 O-methyleugenol decreases expression ISO RGD:1319668 6480464 methyleugenol results in decreased expression of COL8A1 mRNA CTD PMID:32234424 okadaic acid multiple interactions ISO RGD:1319669 6480464 [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of COL8A1 mRNA CTD PMID:19840844 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of COL8A1 mRNA CTD PMID:25729387 paracetamol affects expression ISO RGD:1319669 6480464 Acetaminophen affects the expression of COL8A1 mRNA CTD PMID:17562736 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of COL8A1 mRNA CTD PMID:33387578 paracetamol increases expression ISO RGD:1319668 6480464 Acetaminophen results in increased expression of COL8A1 mRNA CTD PMID:26690555 pentachlorophenol increases expression ISO RGD:1319669 6480464 Pentachlorophenol results in increased expression of COL8A1 mRNA CTD PMID:23892564 permethrin decreases expression ISO RGD:1319668 6480464 Permethrin results in decreased expression of COL8A1 mRNA CTD PMID:37047231 phenylmercury acetate increases expression ISO RGD:1319668 6480464 Phenylmercuric Acetate results in increased expression of COL8A1 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1319668 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL8A1 mRNA CTD PMID:27188386 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:1319669 6480464 [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of COL8A1 mRNA CTD PMID:19840844 phthalaldehyde affects expression ISO RGD:1319669 6480464 o-Phthalaldehyde affects the expression of COL8A1 mRNA CTD PMID:22302311 poly(vinylpyrrolidone) multiple interactions EXP 6480464 [Silver analog co-treated with Povidone] results in increased expression of COL8A1 mRNA CTD PMID:25194297 potassium chromate decreases expression ISO RGD:1319668 6480464 potassium chromate(VI) results in decreased expression of COL8A1 mRNA CTD PMID:22714537 potassium dichromate increases expression ISO RGD:1319669 6480464 Potassium Dichromate results in increased expression of COL8A1 mRNA CTD PMID:23608068 progesterone decreases expression ISO RGD:1319669 6480464 Progesterone results in decreased expression of COL8A1 mRNA CTD PMID:22238285 Rebamipide decreases expression EXP 6480464 rebamipide results in decreased expression of COL8A1 mRNA CTD PMID:15104358 resveratrol multiple interactions ISO RGD:1319668 6480464 [Plant Extracts co-treated with Resveratrol] results in decreased expression of COL8A1 mRNA CTD PMID:23557933 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:1319668 6480464 [S-(1, 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of COL8A1 mRNA CTD PMID:35811015 SB 431542 multiple interactions ISO RGD:1319668 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silver atom multiple interactions EXP 6480464 [Silver analog co-treated with Povidone] results in increased expression of COL8A1 mRNA CTD PMID:25194297 silver(0) multiple interactions EXP 6480464 [Silver analog co-treated with Povidone] results in increased expression of COL8A1 mRNA CTD PMID:25194297 sodium arsenate multiple interactions ISO RGD:1319668 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of COL8A1 mRNA CTD PMID:32525701 sodium arsenite decreases expression ISO RGD:1319668 6480464 sodium arsenite results in decreased expression of COL8A1 mRNA CTD PMID:34032870 succimer multiple interactions ISO RGD:1319669 6480464 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of COL8A1 mRNA CTD PMID:21641980 sunitinib decreases expression ISO RGD:1319668 6480464 Sunitinib results in decreased expression of COL8A1 mRNA CTD PMID:31533062 temozolomide increases expression ISO RGD:1319668 6480464 Temozolomide results in increased expression of COL8A1 mRNA CTD PMID:31758290 tetrachloromethane increases expression ISO RGD:1319669 6480464 Carbon Tetrachloride results in increased expression of COL8A1 mRNA CTD PMID:17484886 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of COL8A1 mRNA CTD PMID:34492290 titanium dioxide increases expression ISO RGD:1319669 6480464 titanium dioxide results in increased expression of COL8A1 mRNA CTD PMID:23557971 , PMID:27760801 titanium dioxide multiple interactions ISO RGD:1319669 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of COL8A1 mRNA CTD PMID:29950665 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of COL8A1 mRNA CTD PMID:25729387 topotecan increases expression EXP 6480464 Topotecan results in increased expression of COL8A1 mRNA CTD PMID:25729387 triclosan decreases expression ISO RGD:1319668 6480464 Triclosan results in decreased expression of COL8A1 mRNA CTD PMID:30510588 trimellitic anhydride increases expression ISO RGD:1319669 6480464 trimellitic anhydride results in increased expression of COL8A1 mRNA CTD PMID:19042947 trimellitic anhydride affects expression ISO RGD:1319669 6480464 trimellitic anhydride affects the expression of COL8A1 mRNA CTD PMID:22302311 triticonazole decreases expression EXP 6480464 triticonazole results in decreased expression of COL8A1 mRNA CTD PMID:36084822 troglitazone decreases expression ISO RGD:1319668 6480464 troglitazone results in decreased expression of COL8A1 mRNA CTD PMID:25572481 valproic acid decreases methylation ISO RGD:1319668 6480464 Valproic Acid results in decreased methylation of COL8A1 gene CTD PMID:29154799 valproic acid decreases expression ISO RGD:1319668 6480464 Valproic Acid results in decreased expression of COL8A1 mRNA CTD PMID:23179753 vancomycin decreases expression ISO RGD:1319669 6480464 Vancomycin results in decreased expression of COL8A1 mRNA CTD PMID:18930951 zinc atom decreases expression ISO RGD:1319668 6480464 Zinc deficiency results in decreased expression of COL8A1 mRNA CTD PMID:18356318 zinc(0) decreases expression ISO RGD:1319668 6480464 Zinc deficiency results in decreased expression of COL8A1 mRNA CTD PMID:18356318